Development of radioimmunoconjugate for diagnosis and management of head-and-neck subclinical cancer and colorectal carcinoma-Reference-Cited by-同舟云学术

Development of radioimmunoconjugate for diagnosis and management of head-and-neck subclinical cancer and colorectal carcinoma

Published:2018-04-09 Issue:4 Volume:53 Page:
ISSN:2175-9790
Container-title:Brazilian Journal of Pharmaceutical Sciences
language:
Short-container-title:Braz. J. Pharm. Sci.

Author:

Benedetto Raquel¹,Massicano Adriana Vidal Fernandes¹,Silva Jefferson Jesus¹,Boas Cristian Antonio Wieczorek Villas¹,Mengatti Jair¹,Araújo Elaine Bortoleti de¹

Affiliation:

1. Institute of Energy and Nuclear Research, Brazil

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/pdf/bjps/v53n4/1984-8250-bjps-53-04-e17039.pdf

Reference26 articles.

1. Development of a spectroscopic assay is difunctional ligand-protein conjugates based on copper;Brady ED;Nucl Med Biol,2004

2. Development and characterization of 89Zr-Labeled panitumumab is immuno-positron emission tomographic imaging of the epidermal growth factor receptor;Chang AJ;Mol Imaging,2013

3. Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes;Cooper MS;Nature Protocols,2006

4. Cure of incurable lymphoma;Denardo GL;Int J Radiat Oncol Biol,2006

5. Phase I and imaging trial of indium-111 labeled anti-epidermal growth factor receptor monoclonal antibody 225 in Patients with squamous cell lung carcinoma;Divgi CR;J Natl Cancer Inst,1991

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DTPA(DOTA)-Nimotuzumab Radiolabeling with Generator-produced Thorium for Radioimmunotherapy of EGFR-overexpressing Carcinomas;Current Radiopharmaceuticals;2023-09

2. Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review;Cancers;2021-06-22

3. Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence;Bioorganic & Medicinal Chemistry;2021-03